Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InfuSystems HoldingsINFU -0.17%84 EV-to-FCF is 20.88 as of Aug. 29, 2026, which is 40% above its 10-year median of 14.96. GuruFocus rates INFU with a GF Score™ of 84/100 and a GF Value™ of $9.27 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 409 Medical Devices & Instruments companies, InfuSystems Holdings ranks better than 58.44% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, InfuSystems Holdings's Enterprise Value is $262.1 Mil.
InfuSystems Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was $12.6 Mil. Therefore, InfuSystems Holdings's EV-to-FCF for today is 20.88.
The historical rank and industry rank for InfuSystems Holdings's EV-to-FCF or its related term are showing as below:
INFU'
s EV-to-FCF Range Over the Past 10 Years
Min: -300.47 Med: 14.96 Max: 2359.27
Current: 20.88
During the past 13 years, the highest EV-to-FCF of InfuSystems Holdings was 2359.27. The lowest was -300.47. And the median was 14.96.
INFU's EV-to-FCF is ranked better than 58.44% of 409
companies
in the Medical Devices & Instruments industry
Industry Median: 24.74
vs INFU: 20.88
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
InfuSystems Holdings's PE Ratio (TTM) for today is calculated as:
InfuSystems Holdings's share price for today is $12.04.
InfuSystems Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.410.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
InfuSystems Holdings EV-to-FCF Related Terms
InfuSystems Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InfuSystems Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's EV-to-FCF falls into.
InfuSystems Holdings's current Enterprise Value is $262.1 Mil.
InfuSystems Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InfuSystems Holdings (INFU) has a EV-to-FCF of 20.88 as of Aug. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on InfuSystems Holdings and its competitors. This is 40% above median its historical median of 14.96. According to the industry distribution chart, InfuSystems Holdings ranks #170 out of 409 companies in the Medical Devices & Instruments industry, placing it in the top 41.6%.
Is InfuSystems Holdings' EV-to-FCF too high?
InfuSystems Holdings' current EV-to-FCF of 20.88 is 40% above median its 10-year median of 14.96. The Medical Devices & Instruments industry median EV-to-FCF is 24.74. InfuSystems Holdings' value of 20.88 is 15.6% below this industry median. Based on the distribution chart, InfuSystems Holdings ranks #170 out of 409 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' EV-to-FCF compare to LUCD and QTRX?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #170 out of 409 companies for EV-to-FCF. This puts InfuSystems Holdings in the upper half of its industry. The industry median EV-to-FCF is 24.74. InfuSystems Holdings' value of 20.88 is 15.6% below this benchmark. While the company's 10-year median is 14.96 vs. the industry median of 24.74, InfuSystems Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.74, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current EV-to-FCF of 20.88 is 15.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current EV-to-FCF is 20.88, which is 40% above median its own 10-year median of 14.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.27, compared to a current price of $12.04 — trading 29.9% above its estimated fair value. The current EV-to-FCF is 20.88, which is 40% above median its 10-year median of 14.96 and 15.6% below the Medical Devices & Instruments industry median of 24.74. InfuSystems Holdings' overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current EV-to-FCF is 20.88 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued.
The current stock price of $12.04 is trading 29.9% above its estimated GF Value™ of $9.27.
GuruFocus considers InfuSystems Holdings to be Modestly Overvalued.
Key valuation signals for INFU:
EV-to-FCF: 20.88 (40% above median its 10-year median of 14.96)
GF Value™: $9.27 vs. price of $12.04 (29.9% above fair value)
Industry Position: 15.6% below the Medical Devices & Instruments median (#170 of 409)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
84GF Score
Get the complete analysis for INFU
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
